Criteria Tisagenlecleucel lymfklierkankerCriteria Axicabtagene ciloleucel lymfklierkankerCriteria zeldzame mutaties bij NSCLC met TKI’sCriteria Ocrelizumab multiple scleroseCriteria Dupilumab chronische rhinosinusitis met neuspoliepenCriteria Omalizumab chronische rhinosinusitis met neuspoliepenCriteria Mepolizumab chronische rhinosinusitis met neuspoliepenCriteria Tezepelumab ernstig astmaCriteria Lenvatinib endometriumcarcinoomCriteria Cemiplimab cervixcarcinoomCriteria Pembrolizumab cervixcarcinoomCriteria Olaparib prostaatcarcinoomCriteria Olaparib mammacarcinoomCriteria Mogamulizumab cutane lymfomenCriteria Difelikefalin jeuk bij hemodialyseCriteria Avelumab blaascarinoomCriteria Pembrolizumab blaascarcinoomCriteria Nivolumab blaascarcinoomCriteria Darvadstrocel ziekte van CrohnStandpunt Ranibizumab prematuren-retinopathieCriteria Pembrolizumab mammacarcinoomCriteria Ipilimumab mesothelioomCriteria Niraparib ovariumcarcinoomCriteria Alpelisib mammacarcinoomCriteria Caplacizumab verworven trombotische tromboytopenische purpuraCriteria Nivolumab mesothelioomCriteria Nivolumab longcarcinoomCriteria Ipilimumab longcarcinoomCriteria Talazoparib mammacarcinoomCriteria Olaparib ovariumcarcinoomCriteria Bevacizumab hepatocellulair carcinoomCriteria Atezolizumab hepatocellulair carcinoom